Follow the Sonoma Pharmaceuticals, Inc. stock price and the full management transaction log of the company, a listed issuer based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Market capitalisation: €5.3m. The latest transaction was filed on 21 June 2024 (Attribution). Among the most active insiders: Thornton Bruce. All data is openly available.
6
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Fundamental score
Ranked 28,144 of 29,064 companies
12.7
score / 100
Value
3
Quality
23
FCF yld-78%
Earn yld-60%
EV/EBITDA·
ROE-85%
Gross mgn38%
Net mgn-16%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.